BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 32694315)

  • 1. Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?
    Albright RH; Joseph RM; Wukich DK; Armstrong DG; Fleischer AE
    Clin Orthop Relat Res; 2020 Dec; 478(12):2869-2888. PubMed ID: 32694315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ostectomy and Medial Plantar Artery Flap Reconstruction for Charcot Foot Ulceration Involving the Midfoot.
    Sato T; Ichioka S
    J Foot Ankle Surg; 2016; 55(3):628-32. PubMed ID: 26190780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mid-Term Outcomes of Reconstruction of Charcot Foot Neuroarthropathy in Diabetic Patients].
    Kučera T; Grinac M; Valtr O; Šponer P
    Acta Chir Orthop Traumatol Cech; 2019; 86(1):51-57. PubMed ID: 30843514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of midfoot Charcot neuroarthropathy with osteomyelitis in patients with diabetes: a systematic review.
    Ramanujam CL; Stuto AC; Zgonis T
    J Wound Care; 2020 Jun; 29(Sup6):S19-S28. PubMed ID: 32530758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramedullary foot fixation for midfoot Charcot neuroarthropathy.
    Lamm BM; Siddiqui NA; Nair AK; LaPorta G
    J Foot Ankle Surg; 2012; 51(4):531-6. PubMed ID: 22632840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Diabetic Charcot Patients With and Without Foot Wounds.
    Wukich DK; Sadoskas D; Vaudreuil NJ; Fourman M
    Foot Ankle Int; 2017 Feb; 38(2):140-148. PubMed ID: 27923212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector Perspective.
    Su HY; Yang CY; Ou HT; Chen SG; Chen JC; Ho HJ; Kuo S
    JAMA Netw Open; 2023 Jan; 6(1):e2250639. PubMed ID: 36633847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical treatment of the Charcot foot : long-term results and systematic review].
    Hartig N; Krenn S; Trnka HJ
    Orthopade; 2015 Jan; 44(1):14-24. PubMed ID: 25586504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deformity and Clinical Outcomes Following Operative Correction of Charcot Foot: A New Classification With Implications for Treatment.
    Pinzur MS; Schiff AP
    Foot Ankle Int; 2018 Mar; 39(3):265-270. PubMed ID: 29172758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors Associated With Major Lower Extremity Amputation After Osseous Diabetic Charcot Reconstruction.
    Elmarsafi T; Anghel EL; Sinkin J; Cooper PS; Steinberg JS; Evans KK; Kim PJ; Attinger CE
    J Foot Ankle Surg; 2019 Mar; 58(2):295-300. PubMed ID: 30850098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse Total Shoulder Arthroplasty Is the Most Cost-effective Treatment Strategy for Proximal Humerus Fractures in Older Adults: A Cost-utility Analysis.
    Abdel Khalik H; Humphries B; Zoratti M; Axelrod D; Kruse C; Ristevski B; Rajaratnam K; Gardner M; Tarride JÉ; Johal H
    Clin Orthop Relat Res; 2022 Oct; 480(10):2013-2026. PubMed ID: 35507306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin Substitutes for Adults With Diabetic Foot Ulcers and Venous Leg Ulcers: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(7):1-165. PubMed ID: 34211616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost comparison: limb salvage versus amputation in diabetic patients with charcot foot.
    Gil J; Schiff AP; Pinzur MS
    Foot Ankle Int; 2013 Aug; 34(8):1097-9. PubMed ID: 23493775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes and Complications of Midfoot Charcot Reconstruction With Intramedullary Beaming.
    Ford SE; Cohen BE; Davis WH; Jones CP
    Foot Ankle Int; 2019 Jan; 40(1):18-23. PubMed ID: 30284492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer.
    Lam SW; Wai M; Lau JE; McNamara M; Earl M; Udeh B
    Pharmacotherapy; 2017 Jan; 37(1):94-103. PubMed ID: 27870079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous surgical repair of a tibialis anterior tendon rupture and diabetic charcot neuroarthropathy of the midfoot: a case report.
    Stapleton JJ
    Clin Podiatr Med Surg; 2013 Oct; 30(4):599-604. PubMed ID: 24075138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary Results of Primary Gastrocnemius-Soleus Recession for Midfoot Charcot Arthropathy.
    Laborde JM; Philbin TM; Chandler PJ; Daigre J
    Foot Ankle Spec; 2016 Apr; 9(2):140-4. PubMed ID: 26395022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan.
    Kobayashi T; Hoshi M; Yuasa A; Arai S; Ikeda M; Matsuda H; Kim SW; Hibi T
    Pharmacoeconomics; 2023 May; 41(5):589-604. PubMed ID: 36884164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.